|
1）Eapen M, Rubinstein P, Zhang MJ, et al. Outcomes of trans- plantation of unrelated donor umbilical cord blood and bone marrow in children with acute leukaemia: a comparison study. Lancet. 2007; 369: 1947-54
|
|
|
|
2）Kurtzberg J, Prasad VK, Carter SL, et al. Results of the Cord Blood Transplantation Study (COBLT): clinical outcomes of unrelated donor umbilical cord blood transplantation in pediatric patients with hematologic malignancies. Blood. 2008; 112: 4318-27
|
|
|
|
|
|
3）Rocha V, Labopin M, Sanz G, et al. Transplants of umbilical-cord blood or bone marrow from unrelated donors in adults with acute leukemia. N Engl J Med. 2004; 351: 2276-85
|
|
|
|
|
|
4）Barker JN, Weisdorf DJ, Wagner JE. Creation of a double chimera after the transplantation of umbilical-cord blood from two partially matched unrelated donors. N Engl J Med. 2001; 344: 1870-1
|
|
|
|
|
|
5）Barker JN, Weisdorf DJ, DeFor TE, et al. Transplantation of 2 partially HLA-matched umbilical cord blood units to enhance engraftment in adults with hematologic malignancy. Blood. 2005; 105: 1343-7
|
|
|
|
|
|
6）MacMillan ML, Weisdorf DJ, Brunstein CG, et al. Acute graft-versus-host disease after unrelated donor umbilical cord blood transplantation: analysis of risk factors. Blood. 2009; 113: 2410-5
|
|
|
|
|
|
7）Rodrigues CA, Sanz G, Brunstein CG, et al. Analysis of risk factors for outcomes after unrelated cord blood transplantation in adults with lymphoid malignancies: a study by the Eurocord-Netcord and Lymphoma Working Party of the European Group for Blood and Marrow Transplantation. J Clin Oncol. 2009; 27: 256-63
|
|
|
|
|
|
8）Rocha V, Gluckman E. Improving outcomes of cord blood transplantation: HLA matching, cell dose and other graft and transplantation-related factors. Br J Haematol. 2009; 147: 262-74
|
|
|
|
|
|
9）Scaradavou A, Brunstein CG, Eapen M, et al. Double unit grafts successfully extend the application of umbilical cord blood transplantation in adults with acute leukemia. Blood. 2013; 121: 752-8
|
|
|
|
|
|
10）Ruggeri A, Sanz G, Bittencourt H, et al. Comparison of outcomes after single or double cord blood transplantation in adults with acute leukemia using different types of myeloablative conditioning regimen, a retrospective study on behalf of Eurocord and the Acute Leukemia Working Party of EBMT. Leukemia. 2014; 28: 779-86
|
|
|
|
|
|
11）Trigg ME, Gingrich R, Goeken N, et al. Low rejection rate when using unrelated or haploidentical donors for children with leukemia undergoing marrow transplantation. Bone Marrow Transplant. 1989; 4: 431-7
|
|
|
|
|
|
12）Henslee-Downey PJ, Parrish RS, Macdonald JS, et al. Combined in vitro and in vivo T lymphocyte depletion for the control of graft-versus-host disease following haploidentical marrow transplant. Transplantation. 1996; 61: 738-45
|
|
|
|
|
|
13）Handgretinger R, Klingebiel T, Lang P, et al. Megadose transplantation of purified peripheral blood CD34＋ progenitor cells from HLA-mismatched parental donors in children. Bone Marrow Transplant. 2001; 27: 777-83
|
|
|
|
|
|
14）Aversa F, Terenzi A, Tabilio A, et al. Full haplotype-mismatched hematopoietic stem cell transplantation: A phase II study in patients with acute leukemia at high risk of relapse. J Clin Oncol. 2005; 23: 3447-54
|
|
|
|
|
|
15）Ciceri F, Labopin M, Aversa F, et al. A survey of fully haploidentical hematopoietic stem cell transplantation in adults with high-risk acute leukemia: A risk factor analysis of outcomes for patients in remission at transplantation. Blood. 2008; 112: 3574-81
|
|
|
|
|
|
16）OʼDonnell PV, Luznik L, Jones RJ, et al. Nonmyeloablative bone marrow transplantation from partially HLA-mismatched related donors using posttransplantation cyclophosphamide. Biol Blood Marrow Transplant. 2002; 8: 377-86
|
|
|
|
|
|
17）Bashey A, Zhang X, Sizemore CA, et al. T-cell-replete HLA-haploidentical hematopoietic transplantation for hematologic malignancies using post-transplantation cyclophosphamide results in outcomes equivalent to those of contemporaneous HLA-matched related and unrelated donor transplantation. J Clin Oncol. 2013; 31: 1310-6
|
|
|
|
|
|
18）Ruggeri A, Labopin M, Sanz G, et al. Comparison of outcomes after unrelated cord blood and unmanipulated haploidentical stem cell transplantation in adults with acute leukemia. Leukemia. 2015 Apr 17. doi: 10.1038/leu.2015.98. [Epub ahead of print]
|
|
|
|
|
|
19）Tolar J, Mehta PA, Walters MC. Hematopoietic cell transplantation for nonmalignant disorders. Biol Blood Marrow Transplant. 2012; 18: S166-71
|
|
|
|
|
|
20）Szabolcs P, Cavazzana-Calvo M, Fischer A, et al. Bone marrow transplantation for primary immunodeficiency diseases. Pediatr Clin North Am. 2010; 57: 207-37
|
|
|
|
|
|
21）Boelens JJ, Prasad VK, Tolar J, et al. Current international perspectives on hematopoietic stem cell transplantation for inherited metabolic disorders. Pediatr Clin North Am. 2010; 57: 123-45
|
|
|
|
|
|
22）Prasad VK, Kurtzberg J. Umbilical cord blood transplantation for non- malignant diseases. Bone Marrow Transplant. 2009; 44: 643-51
|
|
|
|
|
|
23）Eapen M, Ahn KW, Orchard PJ, et al. Long-term survival and late deaths after hematopoietic cell transplantation for primary immunodeficiency diseases and inborn errors of metabolism. Biol Blood Marrow Transplant. 2012; 18: 1438-45
|
|
|
|
|
|
24）Parikh SH, Mendizabal A, Benjamin CL, et al. A novel reduced-intensity conditioning regimen for unrelated umbilical cord blood transplantation in children with nonmalignant diseases. Biol Blood Marrow Transplant. 2014; 20: 326-36
|
|
|
|
|
|
25）Gluckman E, Rocha V, Ionescu I, et al. Results of unrelated cord blood transplant in Fanconi anemia patients: risk factor analysis for engraftment and survival. Biol Blood Marrow Transplant. 2007; 13: 1073-82
|
|
|
|
|
|
26）Yoshimi A, Kojima S, Taniguchi S, et al. Unrelated cord blood transplantation for severe aplastic anemia. Biol Blood Marrow Transplant. 2008; 14: 1057-63
|
|
|
|
|
|
27）Gluckman E, Wagner JE. Hematopoietic stem cell transplantation in childhood inherited bone marrow failure syndrome. Bone Marrow Transplant. 2008; 41: 127-32
|
|
|
|
|
|
28）de Latour RP, Rocha V, Socie G. Cord blood transplantation in aplastic anemia. Bone Marrow Transplant. 2013; 48: 201-2
|
|
|
|
|
|
29）Zecca M, Strocchio L, Pagliara D, et al. HLA-haploidentical T celle depleted allogeneic hematopoietic stem cell transplantation in children with Fanconi anemia. Biol Blood Marrow Transplant. 2014; 20: 571-6
|
|
|
|
|
|
30）Clay J, Kulasekararaj AG, Potter V, et al. Nonmyeloablative peripheral blood haploidentical stem cell transplantation for refractory severe aplastic anemia. Biol Blood Marrow Transplant. 2014; 2014: 1711-6
|
|
|
|
|
|
31）Esteves I, Bonfim C, Pasquini R, et al. Haploidentical BMT and post-transplant Cy for severe aplastic anemia: a multicenter retrospective study. Bone Marrow Transplantation. 2015; 50: 685-9
|
|
|
|
|